Drug profile · INN
maralixibat
LIVMARLI
maralixibat (LIVMARLI) is a ileal bile acid transporter inhibitor.
EMA: application withdrawn Alimentary tract and metabolism (A05) A05AX
Patents linked 1
Pipeline programs 11
News articles 0
Drug details — maralixibat
- Class
- Alimentary tract and metabolism (A05)
- Route
- —
- Patents
- 1
- Programs
- 11
- Data quality
- 0.83
Quick answer
maralixibat (LIVMARLI) is a ileal bile acid transporter inhibitor.
Key facts
INN maralixibat
Brand LIVMARLI
Mechanism Ileal bile acid transporter inhibitor
Target Ileal sodium/bile acid cotransporter
Therapeutic class Alimentary tract and metabolism (A05)
ATC code A05AX
Mechanism of action
Ileal bile acid transporter inhibitor
Primary target: Ileal sodium/bile acid cotransporter
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is maralixibat?
maralixibat (LIVMARLI) is a ileal bile acid transporter inhibitor.
What is the brand name for maralixibat?
LIVMARLI is a marketed brand name for maralixibat. Check FDA Drugs@FDA for the current US label holder and prescribing information.